Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Sponsors
Medtronic Cardiovascular
Conditions
Severe Aortic Stenosis
Unknown Phase
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement
CompletedNCT01240902
Start: 2010-12-10End: 2019-05-15Updated: 2022-10-25
Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement
CompletedNCT01531374
Start: 2012-02-21End: 2019-11-18Updated: 2022-10-25
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
Active, not recruitingNCT01586910
Start: 2012-04-01End: 2026-11-01Updated: 2026-06-24
Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement
CompletedNCT01675440
Start: 2012-08-01End: 2025-04-08Updated: 2026-05-05
Related Papers
25 more papers not shown